Search
for
Sort by
Research 301–330 of 527
- Macrophages as central mediators of sympathetic neuro-immune interplay in autoimmunity
- Mathematical Modeling of Alopecia Areata: Unraveling Hair Cycle Dynamics, Disease Progression, and Treatment Strategies
- Alopecia and Thyroid Disease
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Inhibition of glycosphingolipid synthesis reverses skin inflammation and hair loss in ApoE−/− mice fed western diet
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
- Evaluation of Atherogenic Indexes in Patients With Lichen Planopilaris: A Case-Control Study
- A Temporal Mathematical Model of Alopecia Areata: Investigating Hair Cycle Dynamics and Disease Progression
- Mathematical Modeling of Alopecia Areata: Unraveling Hair Cycle Dynamics, Disease Progression, and Treatment Strategies
- New treatment modalities of alopecia areata
- Retrospektive Analyse von Wirksamkeit, Sicherheit, prognostischen Parametern und Faktoren der Lebensqualität bei der topischen Immuntherapie der Alopecia areata mit Diphenylcyclopropenon
- Vitamin D and the skin: Focus on a complex relationship: A review
- Gender differences in skin: A review of the literature
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Acquired scalp alopecia. Part I: A review
- Differential impact of environmental factors on systemic and localized autoimmunity
- Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis
- Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
- Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets
- CD27 and IL-35 as diagnostic biomarkers in alopecia areata: First evidence of association with pathogenic scalp bacterial infections
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Factors Associated with Severity of Alopecia Areata
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Traditional and Integrative Approaches to the Treatment of Alopecia